[
Barbour, S. J., Coppo, R., Zhang, H., Liu, Z. H., Suzuki, Y., Matsuzaki, K., Katafuchi, R., Er, L., Espino-Hernandez, G., Kim, S. J., Reich, H. N., Feehally, J., Cattran, D. C. (2019). International IgA nephropathy network. Evaluating a new International Risk-Prediction Tool in IgA Nephropathy. JAMA Intern Med., 179 (7), 942–952. Erratum in: JAMA Intern Med., 2019, 179 (7), 1007.
]Search in Google Scholar
[
Barbour, S. J., Espino-Hernandez, G., Reich, H. N., Coppo, R., Roberts, I. S., Feehally, J., Herzenberg, A. M., Cattran, D. C. (2016). The MEST score provides earlier risk prediction in lgA nephropathy. Kidney Int., 89 (1),167–175.10.1038/ki.2015.32226759049
]Search in Google Scholar
[
Chang, A., Laszik, Z. (2018). Kidney and its collecting system. In: Vinay, K., Abbas, A. K., Aster, J. C. (eds.). Robbins Basic Pathology. Elsevier, Philadelphia, Chapter 14, pp. 549–581.
]Search in Google Scholar
[
Chen, D., Liu, J., Duan, S., Chen, P., Tang, L., Zhang, L., Feng, Z., Cai, G., Wu, J., Chen, X. (2018). Clinicopathological features to predict Pprogression of IgA nephropathy with mild proteinuria. Kidney Blood Press Res., 43 (2), 318–328.10.1159/00048790129529608
]Search in Google Scholar
[
Cheng, J., Zhang, W., Zhang, X. H., He, Q., Tao, X. J., Chen, J. H. (2009). ACEI/ARB therapy for IgA nephropathy: A meta-analysis of randomised controlled trials. Int. J. Clin. Pract., 63 (6), 880–888.10.1111/j.1742-1241.2009.02038.x19490198
]Search in Google Scholar
[
Cheng, Y. S., Barratt, J. (2018). Immunoglobulin A nephropathy and related disorders. In: Gilbert, S., Weiner, D. E. National Kidney Foundation Primer on Kidney Diseases. Elsevier, Edinburgh. 680 pp.
]Search in Google Scholar
[
Cheung, C. K., Barratt, J. (2020). IgA nephropathy: Pathogenesis. https://www.uptodate.com/contents/iga-nephropathy-pathogenesis (accessed 15.09.2021).
]Search in Google Scholar
[
Coppo, R., D’Arrigo, G., Tripepi, G., Russo, M. L., Roberts, I. S. D., Bellur, S., Cattran, D., Cook, T. H., Feehally, J., Tesar, V., et al. (2020). Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update. Nephrol. Dial. Transplant., 35 (6), 1002–1009.10.1093/ndt/gfy30230418652
]Search in Google Scholar
[
Duan, Z. Y., Cai, G. Y., Chen, Y. Z., Liang, S., Liu, S. W., Wu, J., Qiu, Q., Lin, S. P., Zhang, X. G., Chen, X. M. (2013). Aging promotes progression of IgA nephropathy: A systematic review and meta-analysis. Amer. J. Nephrol., 38 (3), 241–252.10.1159/00035464624021632
]Search in Google Scholar
[
Geddes, C. C., Rauta, V., Gronhagen-Riska, C., Bartosik, L. P., Jardine, A. G., Ibels, L. S., Pei, Y., Cattran, D. C. (2003). A tricontinental view of IgA nephropathy. Nephrol. Dial. Transplant., 18 (8), 1541–1548.10.1093/ndt/gfg20712897092
]Search in Google Scholar
[
eGFR using CKD-EPI. https://qxmd.com/calculate/calculator_251/egfr-using-ckd-epi (accessed 15.09.2021).
]Search in Google Scholar
[
Hennino, M., Buob, D., van der, Hauwaert, C., Gnemmi, V., Jomaa, Z., Pottier, N., Savary, G., Drumez, E., Noël, C., Cauffiez, C., Glowacki, F. (2016). miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy. Sci. Rep., 6, 27209 (2016).
]Search in Google Scholar
[
Kiryluk, K., Li, Y., Sanna-Cherchi, S., Rohanizadegan, M., Suzuki, H., Eitner, F., Snyder, H. J., Choi, M., Hou, P., Scolari, F., et al. (2012). Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Gen., 8 (6), e1002765.10.1371/journal.pgen.1002765338084022737082
]Search in Google Scholar
[
Krūmiņa, A., Pliss, L., Zariņa, G., Puzuka, A., Zariņa, A., Lāce, B., Elferts, D., Khrunin, A., Limborska, S., Kloviņš, J., Gailīte Piekuse, L. (2018). Population genetics of Latvians in the context of admixture between North-Eastern European ethnic groups. Proc. Latvian Acad. Sci., Section B, 72 (3), 131–151.10.2478/prolas-2018-0025
]Search in Google Scholar
[
Lai, K., Tang, S., Schena, F., Novak, J., Tomino, Y., Fogo, A. B., Glassock, R. J. (2016). IgA nephropathy. Nat. Rev. Dis. Primers, 2, 16001.10.1038/nrdp.2016.127189177
]Search in Google Scholar
[
McGrogan, A., Franssen, C. F. M., Vries, C. S. (2011). The incidence of primary glomerulonephritis worldwide: A systematic review of the literature. Nephrol. Dial. Transplant., 26 (2), 414–430.10.1093/ndt/gfq66521068142
]Search in Google Scholar
[
Moriyama, T., Tanaka, K., Iwasaki, C., Oshima, Y., Ochi, A., Kataoka, H., Itabashi, M., Takei, T., Uchida, K., Nitta, K. (2014). Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLoS One, 9 (3), e91756.10.1371/journal.pone.0091756396237324658533
]Search in Google Scholar
[
Nagy, J., Kovács, T., Wittmann, I. (2005). Renal protection in IgA nephropathy requires strict blood pressure control. Nephrol. Dial. Transplant., 20 (8), 1533–1539.10.1093/ndt/gfh92015956069
]Search in Google Scholar
[
New International IgAN Prediction Tool. https://qxmd.com/calculate/calculator_499/international-igan-prediction-tool (accessed 13.10.2021).
]Search in Google Scholar
[
Rauen, T., Fitzner, C., Eitner, F., Sommerer, C., Zeier, M., Otte, B., Panzer, U., Peters, H., Benck, U., Mertens, P. R. et al. (2018). Effects of two immunosuppressive treatment protocols for IgA nephropathy. J. Amer. Soc. Nephrol.,, 29 (1) 317–325.10.1681/ASN.2017060713574892529042456
]Search in Google Scholar
[
Roberts, I. S.D. (2019). Kidney diseases. In: Cross, S. S. (Ed.). Underwood’s Pathology: A Clinical Approach. Elsevier, Edinburgh, pp. 494–522.
]Search in Google Scholar
[
Rodrigues, J. C., Haas, M., Reich, H. N. (2017). IgA Nephropathy. Clin. J. Amer. Soc. Nephrol., 12 (4), 677–686.10.2215/CJN.07420716538338628159829
]Search in Google Scholar
[
Schena, F. P., Nistor, I. (2018). Epidemiology of IgA nephropathy: A global perspective. Seminars in Nephrology, 38 (5), 435–442.10.1016/j.semnephrol.2018.05.01330177015
]Search in Google Scholar
[
Schimpf, J. I., Klein, T., Fitzner, C., Eitner, F., Porubsky, S., Hilgers, R. D., Floege, J., Groene, H. J., Rauen, T. (2018). Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores). BMC Nephrol., 19 (1), 328.10.1186/s12882-018-1128-6624578130453889
]Search in Google Scholar
[
Silbiger, S. R. (2011). Raging hormones: Gender and renal disease. Kidney Int., 79 (4), 382–384.10.1038/ki.2010.47421278778
]Search in Google Scholar
[
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y., Castro, III, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., van Lente, F., Greene, T., Coresh, J. (2009). A new equation to estimate glomerular filtration rate. Ann. Intern. Med., 150, 604–612.10.7326/0003-4819-150-9-200905050-00006276356419414839
]Search in Google Scholar
[
The International IgA NEPHROPATHY (IgAN). Prediction Tool Information for nephrologists and other healthcare professionals. https://ukkidney.org/sites/renal.org/files/2-IgAN-Risk-Prediction-Tool-info-for-Health-Professionals.pdf (accessed 15.09.2021).
]Search in Google Scholar
[
Zhang, J., Huang, B., Liu, Z., Wang, X., Xie, M., Guo, R., Wang, Y., Yu, D., Wang, P., Zhu, Y., Ren, J. (2020). External validation of the International IgA Nephropathy Prediction Tool. Clin. J. Amer. Soc. Nephrol., 15 (8) 1112–1120.10.2215/CJN.16021219740975332616496
]Search in Google Scholar